Skip to content
AnalystLens

Idex Quarterly Report for Q2 Ended Jun 30, 2025

Filing Date
Filed July 30, 2025
Period End
June 30, 2025
Security
IEX
One revenue dollarkept$0.15
In the record · 2016–202610-K1110-Q338-K119

IEX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jan ’18Jan ’18
  2. Material agreement8-K · Apr ’20Apr ’20
  3. Leadership change8-K · Sep ’22Sep ’22
  4. Material agreement8-K · Sep ’26Sep ’26

Summary

Summary of the 10-Q filed July 30, 2025. Cited figures are marked; the original filing is the authoritative source.

IDEX Corporation's second-quarter 2025 Form 10-Q reports net sales of $865.4 milliona for the three months ended June 30, 2025, up 7% from $807.2 million a year earlier, with the filing noting organic sales increased 1%, driven by the Mott Corporation acquisition.

Reported diluted EPS attributable to IDEX was $1.74b, down 6% from $1.86, reflecting higher amortization and interest expense tied to the Mott financing; the filing states adjusted diluted EPS of $2.07 was relatively flat. For the six months, net sales were $1,679.7 million (up 4%), and diluted EPS was $3.00 versus $3.46, with restructuring expenses rising to $18.2 million from $2.4 million due to organizational changes and severance. Gross margin was 45.3% for the quarter, essentially flat versus 45.4%, as price/cost and productivity gains offset volume deleverage and unfavorable mix.

Segment Adjusted EBITDA was $260.1 millionc for the quarter, and consolidated Adjusted EBITDA was $237.2 million. Operating cash flow was $267.4 million for the six months, down from $290.2 million, and free cash flow was $238.3 million. Cash and equivalents stood at $568.2 million, total borrowings at $1,857.9 million, and the company repurchased $100.0 million of stock in the first half of 2025.

Subsequent to the quarter, IDEX acquired Micro-LAM, Inc. on July 29, 2025 for $90.0 million in cash plus a potential earnout of up to $12.0 milliond, funded with revolver borrowings. The filing also states the company was in compliance with its financial covenants, with an interest coverage ratio of 12.94 to 1 against a 3.0 to 1 minimum and a leverage ratio of 2.08 to 1 against a 3.50 to 1 maximum.

Key Highlights

  1. Net sales of $865.4 million for Q2 2025, up 7% overall and up 1% organically, with the filing describing it as a record for reported net sales.
  2. Diluted EPS attributable to IDEX was $1.74, down 6% from $1.86; adjusted diluted EPS was $2.07, which the filing describes as relatively flat.
  3. Gross margin was 45.3% versus 45.4% a year earlier; the filing cites price/cost gains offset by volume deleverage and unfavorable mix.
  4. Restructuring expenses and asset impairments rose to $18.2 million for the six months from $2.4 million, tied to 2025 organizational changes and severance.
  5. Operating cash flow was $267.4 million for the six months (vs. $290.2 million), and free cash flow was $238.3 million (vs. $254.3 million).
  6. The company repurchased $100.0 million of common stock in the first half of 2025, with $439.7 million of authorization remaining at June 30, 2025.
  7. Micro-LAM, Inc. was acquired on July 29, 2025 for $90.0 million in cash plus up to $12.0 million in potential earnout, funded through the Revolving Facility.

Follow one dollar

Of each $1.00 of revenue in Q2 FY2025, Idex kept $0.15.

  1. Revenue$865.4M100.0%
  2. Cost of revenue−$473.2M54.7%
  3. Gross profit$392.2M45.3%
  4. Operating costs−$204.3M23.6%
  5. Operating income$187.9M21.7%
  6. Interest, other & tax−$56.3M6.5%
  7. Net income$131.6M15.2%
Computed from 10-QQ2 FY2025filed July 30, 2025Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Financial Statements

Q2 FY2025 against Q2 FY2024

Line itemQ2 FY2025Q2 FY2024Change
Revenue$865.40M$807.20M+7.2%
Cost of Revenue$473.20M$440.40M+7.4%
Gross Profit$392.20M$366.80M+6.9%
SG&A Expenses$203.60M$182.80M+11.4%
Operating Income$187.90M$182.70M+2.8%
Net Income$131.60M$141.30M−6.9%
EPS (Basic)$1.74$1.86−6.5%
EPS (Diluted)$1.74$1.86−6.5%
Shares Outstanding (Basic)75.50M75.70M−0.3%
Shares Outstanding (Diluted)75.50M75.90M−0.5%

Frequently Asked Questions

  1. How did IDEX perform in the second quarter of 2025?

    Net sales were $865.4 million, up 7% reported and up 1% organically, with the Mott acquisition contributing. Net income attributable to IDEX was $131.6 million, and diluted EPS was $1.74, down from $1.86 in the prior year period.

  2. Why did reported diluted EPS decline while adjusted EPS held steady?

    The filing attributes the reported EPS decline to higher amortization expense and interest costs related to the Mott financing. Adjusted diluted EPS, which excludes items such as acquisition-related intangible amortization and restructuring, was $2.07, described as relatively flat versus $2.06.

  3. What is the company's liquidity and leverage position?

    At June 30, 2025, cash and cash equivalents were $568.2 million, total borrowings were $1,857.9 million, and Revolving Facility availability was $540.6 million. The leverage ratio was 2.08 to 1 against a 3.50 to 1 maximum covenant, and the company stated it was in compliance with its covenants.

  4. What recent acquisition and capital allocation activity should investors note?

    IDEX acquired Mott Corporation in September 2024, and in July 2025 acquired Micro-LAM, Inc. for $90.0 million plus up to $12.0 million in earnout, funded by revolver borrowings. In the first half of 2025, the company paid $105.9 million in dividends and repurchased $100.0 million of stock.

  5. What drove the change in operating cash flow and what is expected from restructuring?

    Operating cash flow decreased $22.8 million, primarily due to higher investments in operating working capital from early-year inventory builds, higher severance payments, and higher interest payments. The company expects additional restructuring charges of approximately $3 million to $7 million during the remainder of 2025.